Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16905628 | 0.96 | KDM4E (0.40) | KDM4EATML3MBTL1NPY5RPTGER4 | |
| SCHEMBL19246503 | 0.94 | L3MBTL1 (0.40) | KDM4EATML3MBTL1HSD17B10PDE1B | |
| SCHEMBL19246417 | 0.93 | L3MBTL1 (0.39) | KDM4EATML3MBTL1HSD17B10PDE1B | |
| SCHEMBL21736365 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1NPY5RPTGER4 | |
| SCHEMBL18853503 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1NPY5RPTGER4 | |
| SCHEMBL19246582 | 0.90 | L3MBTL1 (0.38) | KDM4EATML3MBTL1HSD17B10PDE1B | |
| SCHEMBL16905632 | 0.89 | KDM4E (0.40) | KDM4EATML3MBTL1HSD17B10PDE1B | |
| SCHEMBL18961941 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL18962061 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL16905742 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1HSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170092890-A1 | Light-Emitting Element, Display Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-03-30 | — | — | US | disclosed |
| US-20170092890-A1 | Light-Emitting Element, Display Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170092890-A1 | Light-Emitting Element, Display Device, Electronic Device, and Lighting Device | SUN2, EHD1, ESR1 | KDM4E 1830/4885ATM 3207/4885L3MBTL1 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.